DKBmed Launches New Webcast: Managing MS in Era of COVID-19
Email: [email protected]
NEW YORK (1/3/2022) – DKBmed, LLC has developed an intelligent webcast entitled Managing MS in the Era of COVID-19 through the ArcheMedX Intelligent Learning Platform (ILP). Learners participating in this program can better understand how to treat patients with multiple sclerosis (MS) during the ongoing COVID-19 pandemic.
The program can be found at covid19.dkbmed.com/multispecialty/managing-ms
As a condition with no cure, MS is managed through the use of immunomodulatory, disease-modifying therapies (DMTs). Although these medications are effective for patients with relapsing-remitting MS, the treatments elevate the risk for opportunistic infections. Results from studies suggest that many people diagnosed with MS, particularly those with comorbid conditions, have a heighted chance of developing severe cases of COVID-19. Additionally, some evidence indicates that certain classes of treatment are associated with COVID-19 severity. Because the likelihood of complications from COVID-19 is heightened in this patient population, clinicians need to take steps to mitigate risk and promote patient safety.
“COVID-19 has dramatically altered the treatment of patients with chronic conditions, and those with MS are no exception” notes Joseph Sabatino, Jr., MD, PhD, Assistant Adjunct Professor, Department of Neurology at University of California San Francisco. “As our understanding of how to combat COVID-19 evolves, so too must our strategies for caring for patients with MS. We need to be knowledgeable about strategies that maintain patient safety without sacrificing treatment efficacy.”
This webinar will inform clinicians on how to:
- Analyze how COVID-19 may affect MS care and long-term patient outcomes
- Determine strategies to stay safe while treating patients with MS during the COVID-19 pandemic
The webinar allows learners to engage with the latest data on treatments, results from studies on the effects of COVID-19 on patients with MS, as well as recommendations published by the National MS Society. Each participant in the program will also have access to a personalized learner dashboard that promotes active study and deeper dives into specific topics of interest.
Managing MS in the Era of COVID-19 is a component of DKBmed’s successful COVID-19: Keeping Up with a Moving Target program. Since its inception in March 2020, this initiative has reached over 125,000 clinicians worldwide and features more than 100 programs. The ongoing series of webinars and podcasts are freely accessible at any time on DKBmed’s Hub website covid19.dkbmed.com.
About the Postgraduate Institute for Medicine The Postgraduate Institute for Medicine (PIM) has been providing trusted, independent continuing education for healthcare professionals for over 30 years and is a recognized leader for jointly sponsored and cosponsored continuing education activities. PIM is accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Psychological Association (APA), and accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission (ANCC) on accreditation.
About ArcheMedX ILP The ArcheMedX ILP is a system that intelligently maps medical education content and assesses learner engagement in real-time to curate customized learning experiences. Participants are driven to reflect and engage with content by answering questions, taking notes, and viewing additional resources. By organizing content into one place, ArcheMedX ILP offers users a streamlined, elegant learning experience. To learn more about the features of the ArcheMedX ILP, visit the company website at: https://www.archemedx.com/intelligent-learning-platform/
About DKBmed DKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.
Working with accredited providers and other partners, DKBmed develops innovative educational programs and quality improvement (QI) initiatives, bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in Pain Management, HIV, Depression, Influenza, and Diabetic Eye Disease. DKBmed was also an early adopter of case scenarios with real patients and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, and smart phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn and access educational programs in a manner that is most convenient and appropriate for them.
DKBmed’s programs are accessible through the company’s website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.